349 related articles for article (PubMed ID: 17289495)
1. Alternative anticoagulation management strategies for the patient with heparin-induced thrombocytopenia undergoing cardiac surgery.
Murphy GS; Marymont JH
J Cardiothorac Vasc Anesth; 2007 Feb; 21(1):113-26. PubMed ID: 17289495
[No Abstract] [Full Text] [Related]
2. Heparin-induced thrombocytopenia. A contemporary clinical approach to diagnosis and management.
Shantsila E; Lip GYH; Chong BH
Chest; 2009 Jun; 135(6):1651-1664. PubMed ID: 19497901
[TBL] [Abstract][Full Text] [Related]
3. [Heparin induced thrombocytopenia and anticoagulation in renal replacemant therapy].
Steinfeldt T; Rolfes C
Anasthesiol Intensivmed Notfallmed Schmerzther; 2008 Apr; 43(4):304-10; quiz 312. PubMed ID: 18409125
[TBL] [Abstract][Full Text] [Related]
4. [Current treatment concepts in heparin-induced thrombocytopenia].
Ranze O; Greinacher A
Dtsch Med Wochenschr; 1999 Jul; 124(28-29):865-73. PubMed ID: 10432950
[No Abstract] [Full Text] [Related]
5. Cardiopulmonary bypass with danaparoid sodium and ancrod in heparin-induced thrombocytopenia.
Kanagasabay RR; Unsworth-White MJ; Robinson G; Bevan D; Farnsworth G; Haxby EJ; Smith EE
Ann Thorac Surg; 1998 Aug; 66(2):567-9. PubMed ID: 9725413
[TBL] [Abstract][Full Text] [Related]
6. Parenteral anticoagulants: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.
Garcia DA; Baglin TP; Weitz JI; Samama MM
Chest; 2012 Feb; 141(2 Suppl):e24S-e43S. PubMed ID: 22315264
[TBL] [Abstract][Full Text] [Related]
7. Heparin-induced thrombocytopenia and thrombosis.
Patel VP; Bong M; Di Cesare PE
Am J Orthop (Belle Mead NJ); 2007 May; 36(5):255-60. PubMed ID: 17571830
[TBL] [Abstract][Full Text] [Related]
8. Use of danaparoid sodium (Orgaran) as an alternative to heparin sodium during cardiopulmonary bypass: a clinical evaluation of six cases.
Fernandes P; Mayer R; MacDonald JL; Cleland AG; Hay-McKay C
Perfusion; 2000 Nov; 15(6):531-9. PubMed ID: 11131218
[TBL] [Abstract][Full Text] [Related]
9. Heparin induced thrombocytopenia: pathogenetic, clinical, diagnostic and therapeutic aspects.
Castelli R; Cassinerio E; Cappellini MD; Porro F; Graziadei G; Fabris F
Cardiovasc Hematol Disord Drug Targets; 2007 Sep; 7(3):153-62. PubMed ID: 17896955
[TBL] [Abstract][Full Text] [Related]
10. Parenteral anticoagulants: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).
Hirsh J; Bauer KA; Donati MB; Gould M; Samama MM; Weitz JI
Chest; 2008 Jun; 133(6 Suppl):141S-159S. PubMed ID: 18574264
[TBL] [Abstract][Full Text] [Related]
11. Lifesaving citrate anticoagulation to bridge ineffective danaparoid [correction of to bridge to danaparoid] treatment.
Dworschak M; Hiesmayr JM; Lassnigg A
Ann Thorac Surg; 2002 May; 73(5):1626-7. PubMed ID: 12022563
[TBL] [Abstract][Full Text] [Related]
12. Heparin-induced thrombocytopenia and cardiovascular diseases.
Das P; Ziada K; Steinhubl SR; Moliterno DJ; Hamdalla H; Jozic J; Mukherjee D
Am Heart J; 2006 Jul; 152(1):19-26. PubMed ID: 16824828
[No Abstract] [Full Text] [Related]
13. Orgaran (Org 10172) for cardiopulmonary bypass in heparin-induced thrombocytopenia: role of adjunctive plasmapheresis.
Schmahl KS; Ganjoo AK; Harloff MG
J Cardiothorac Vasc Anesth; 1997 Apr; 11(2):262-3. PubMed ID: 9106004
[No Abstract] [Full Text] [Related]
14. Coagulation complicating cardiopulmonary bypass in a patient with heparin-induced thrombocytopenia receiving the heparinoid, danaparoid sodium.
Grocott HP; Root J; Berkowitz SD; deBruijn N; Landolfo K
J Cardiothorac Vasc Anesth; 1997 Dec; 11(7):875-7. PubMed ID: 9412888
[No Abstract] [Full Text] [Related]
15. Treatment of heparin-induced thrombocytopenia in cardiovascular patients.
Matthai WH
Expert Opin Pharmacother; 2006 Feb; 7(3):267-76. PubMed ID: 16448321
[TBL] [Abstract][Full Text] [Related]
16. Hitting back HIT.
Gude D
Ann Card Anaesth; 2012; 15(2):168-9. PubMed ID: 22508216
[No Abstract] [Full Text] [Related]
17. [Use of low molecular weight heparins by dermatologists].
Maakaroun A; Gruel Y
Ann Dermatol Venereol; 2003 Apr; 130(4):473-8. PubMed ID: 12843865
[No Abstract] [Full Text] [Related]
18. Direct thrombin inhibitors in patients with mechanical heart valves: ready for clinical trials?
Rupprecht HJ
Thromb Haemost; 2009 Jun; 101(6):995-6. PubMed ID: 19492137
[No Abstract] [Full Text] [Related]
19. [Successful therapy of heparin-associated thrombocytopenia with a low sulfated heparinoid].
Herzog S; Rath W; Kuhn W
Geburtshilfe Frauenheilkd; 1995 Mar; 55(3):164-6. PubMed ID: 7665065
[TBL] [Abstract][Full Text] [Related]
20. Heparin-induced thrombocytopenia: what clinicians need to know.
Chong BH; Isaacs A
Thromb Haemost; 2009 Feb; 101(2):279-83. PubMed ID: 19190810
[No Abstract] [Full Text] [Related]
[Next] [New Search]
